Home Newsletters Immunology of Infectious Disease News Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based...

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

0
Pfizer, Inc. and BioNTech SE announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles.
[Pfizer, Inc.]

Sorry, but the selected Zotpress account can't be found.

Press Release
Exit mobile version